InvestorsHub Logo
Followers 14
Posts 773
Boards Moderated 0
Alias Born 06/21/2015

Re: None

Tuesday, 07/24/2018 3:01:37 AM

Tuesday, July 24, 2018 3:01:37 AM

Post# of 205097
Just a reminder that Theranos' deal with Safeway/Albertsons was worth $350 million for 800 locations to use their blood testing technologies. That deal fell apart when the technology was proven to be a massive fraud. This time around, Arrayit accomplished the one thing Theranos couldn't do - transparency and tests validated by Albertsons chief medical officer. They are stepping in and will benefit from this enormous opportunity that Theranos blew.